Cargando…

Elderly Former Smoker with HRAS Mutant Non–Small-Cell Lung Cancer

Detalles Bibliográficos
Autores principales:	Cathcart-Rake, Elizabeth, Corless, Christopher, Sauer, David, Lopez-Chavez, Ariel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165475/ https://www.ncbi.nlm.nih.gov/pubmed/25521407 http://dx.doi.org/10.1097/JTO.0000000000000315

Ejemplares similares

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast
por: Bièche, Ivan, et al.
Publicado: (2021)

WITHDRAWN: Smoker, former smoker and COVID-19
por: Moril-Huaranga, Mariela, et al.
Publicado: (2021)

Mutant HRAS as novel target for MEK and mTOR inhibitors
por: Kiessling, Michael K., et al.
Publicado: (2015)

Plasma cathelicidin and longitudinal lung function in current and former smokers
por: Burkes, Robert M., et al.
Publicado: (2019)

Regional lung function in nonsmokers and asymptomatic current and former smokers
por: Vogt, Barbara, et al.
Publicado: (2019)

Spectrum of ALDH1 mRNA in smokers and non-smokers with adenocarcinoma or squamous cell lung carcinoma
por: Liu, Da-Hua, et al.
Publicado: (2019)

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

The Attentional Bias in Current and Former Smokers
por: Masiero, Marianna, et al.
Publicado: (2019)

Current and former smokers and hip fractures
por: Ampelas, Dimitris G.
Publicado: (2018)

Ideal Cardiovascular Health in Former Smokers
por: Leopold, Jane A., et al.
Publicado: (2021)

PD-1/PD-L1 inhibitors as a hope for smokers of non-small cell lung cancer patient
por: Yu, Zhuo, et al.
Publicado: (2019)

We need to educate young lung cancer patients about menopause risk
por: Faruqi, Fahad, et al.
Publicado: (2019)

Massive Relief: Papillary Adenoma of the Lung in Asymptomatic Former Smoker Patient
por: Stojšić, Jelena, et al.
Publicado: (2020)

COVID-19 Disease Course in Former Smokers, Smokers and COPD Patients
por: Alberca, Ricardo Wesley, et al.
Publicado: (2021)

Are Complication Rates of Breast Reduction Similar in Former Smokers and Never Smokers?
por: Cruz, Norma
Publicado: (2021)

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

Cooperative Genomic Lesions in HRAS-Mutant Cancers Predict Resistance to Farnesyltransferase Inhibitors
por: Nigam, Aradhya, et al.
Publicado: (2023)

Epigenetic modelling of former, current and never smokers
por: Langdon, Ryan J., et al.
Publicado: (2021)

AGER expression and alternative splicing in bronchial biopsies of smokers and never smokers
por: Faiz, Alen, et al.
Publicado: (2019)

Descriptive characteristics of hospitalized adult smokers and never-smokers with COVID-19
por: Kalan, Mohammad Ebrahimi, et al.
Publicado: (2020)

Lung cancer prediction using machine learning on data from a symptom e-questionnaire for never smokers, formers smokers and current smokers
por: Nemlander, Elinor, et al.
Publicado: (2022)

Former smokers with non‐small‐cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis
por: Zheng, Shanbo, et al.
Publicado: (2016)

Some Aspects of Nonbeverage Alcohol Consumption in the Former Soviet Union
por: Jargin, S. V.
Publicado: (2015)

Health Profiles of Current and Former Smokers and Lifelong Abstainers
por: Tang, Jinling, et al.
Publicado: (1997)

Peripheral blood microbial signatures in current and former smokers
por: Morrow, Jarrett D., et al.
Publicado: (2021)

Of Skiers, Smokers And Amelioration Of The World
por: Bernhard, David
Publicado: (2005)

C-reactive protein as a predictor of disease in smokers and former smokers: a review
por: Tonstad, S, et al.
Publicado: (2009)

Deep sequencing of the microRNA transcriptome in current, former, and never smokers with lung adenocarcinoma
por: Wang, Teresa W, et al.
Publicado: (2012)

Clinical characteristics and outcomes of Chinese patients with KRAS‐mutant non‐small cell lung cancer after chemotherapy
por: Zheng, Yawen, et al.
Publicado: (2021)

Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma
por: Gafar, Fajri, et al.
Publicado: (2018)

Argonaute 2 modulates EGFR–RAS signaling to promote mutant HRAS and NRAS-driven malignancies
por: Siebenaler, Ronald F, et al.
Publicado: (2022)

Comment on “Some Aspects of Nonbeverage Alcohol Consumption in the Former Soviet Union”
por: Razvodovsky, Y. E.
Publicado: (2015)

WITHDRAWN: Smoker, Former Smoker and COVID-19: Nicotine Does Not Protect Against SARS-CoV-2
por: Jiménez-Ruiz, Carlos Andrés, et al.
Publicado: (2021)

Psychological morbidity as a moderator of intention to quit smoking: a study of smokers and former smokers
por: Afonso, Maria Fernanda Besteiro, et al.
Publicado: (2013)

Chronic traumatic encephalopathy in two former Australian National Rugby League players
por: Buckland, Michael E., et al.
Publicado: (2019)

The Impact of Socio-Economic Status on Obesity of Adolescents in the Largest Municipality in the Former Yugoslavia
por: Malovic, Pavle, et al.
Publicado: (2021)

Trabecular bone score in active or former smokers with and without COPD
por: González, Jessica, et al.
Publicado: (2019)

Delay discounting in e-cigarette users, current and former smokers
por: Weidberg, Sara, et al.
Publicado: (2017)

In favour of tobacco control? Former smokers’ support for tobacco policies
por: Sohlberg, Tove
Publicado: (2019)

Tell-tale signs of a chronic smoker
por: Chauhan, Vivek, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nlvghqqs2iso3ffsnb3j1ul54s